The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Since we were looking at a value of 700 with proven efficacy of Sng then surely we are a bargain buyout at 200ish floated around here so the big boys can then take better control of the development and rollout of SNG001 proven treatment benefits through their trials and experience with getting things to market, not to mention their manufacturing etc still a med term hold
Sng and RM will review the full dataset and update in due course re the development of SNG001
Everything else assuming this is the end of SNG001 given all the other promising data and other trials is total incorrect conclusion to reach. This helps shape the development and target areas of SNG001 as part of its development
I have had a huge loss today but to sell the remaining is bonkers as this is just part of the SNG001 development not end of SNG001 of that I’m sure
Even if it is worst case that SNG001 has no benefit at all which we already know is not true due to huge benefits in earlier trials maybe with more lung infecting strains etc such copd development and targeting is still much needed
Manifesto I think I’m agreeing with you here that we already know Sng in trials without steroids etc performs well but I think this was a curve ball to RM and synairgen trial as difficult to prove effectiveness in that case which is not the ideal basis for their trial but other trials will prove this benefit as a separate option to other steroids or soc treatments
My point is that of course you must give standard of care as well as Sng in hospital we want people to recover of course and so the benefit of Sng in this case can not be determined so end point not met
But I think it has already proven as preventing hospitalisation in earlier trials as a at home use drug I just see that as it’s place in the treatment as well as of course an extra in the hospital setting
This just better defines where in the stages of the disease it should be used ie at home early on as a preventative for copd type or vulnerable respiratory patients
Current and later trials will prove the development and market place of this beneficial treatment
Sell now and lose £300 value remaining compared to hold until it finds its place in the market for £3k or more even hmmm honestly couldn’t care if it goes to zero because that is no more a loss than now but can honestly see it’s place being well justified now as it’s development and rollout to market continues- as noted that RM will update the market soon likely to this effect that this is helping to define its place rather than write it off as having no place
Pattagucci totally agree this trial didn’t show clear positives when combined with other standard of care etc but all those points you make are still valid for it in reducing severe illness in covid and respiratory diseases.
Totally gutted but don’t think it’s the end of sng0001 as a treatment option for all it’s possible beneficial scenarios of use
Panorama tonight many countries less than 1% vaccinated plus mutations plus easy access and can be used at home to treat early on after detection with results already proven I think it has a place and will come to market as one of many beneficial treatments
I think its clearly shown that there is a reduction in serious disease and death which ongoing trials will hopefully prove ie the activ 2 phase 3- dies anyone know when that is due as u think the timescale is months and not years
It clearly has most benefit as preventing fron early on probably in at home or early hospital but not when already in hospital on other steroids etc (which has masked this trial)
When that is clarified in current trials and from better analysis of the data it will be one of many useful tools in preventing hospitalization and severe illness of covid and other respiratory diseases (for which theres not always a vaccine handy of course) or for the many millions around the world unvaccinated or when it mutated and tget need w early mid stage treatment)
I see it will work out and be an approved treatment for such diseases
I agree that standards of care have improved which has masked this effect of sng thatbwas already proven in earlier trials...if you are in a trial you will still take other care also but it does say that it reduced the hospitilisation rate in the rns I believe...i think future trials pending will show there is still some value in the treatment for covid and other copd related respiratory diseases...still a drug coming to market I'd say which is when value will be realised and bounce back...problem is that could be months away but as I dont need the money right now sell is ridiculous so hold for the later value
Clearly the rns was saying the end points were not achieved because those treated also had other treatments so not really a fair trial but clearly a significant value as a treatment itself as other trials showed and likely future ones will. I say this is still a treatment even though the results are not great form this last scenario...hold to recover upto 120-150
How have we gone from 550 to 350 in about 2 days btw!? Surely this is in breach of some kind of market valuation trading rules to drop so much for no apparent reason???
This is basically nothing concrete!!!! At all! It is a study to look at ways to mine more efficiently...actually going ahead or Actually turning this into value is not confirmed and is many years off at best!!!! As this is a day trade stock expect a BIG SELL OFF when that penny drops until any actual real developments might happen, possibly. I work in Engineering I know how these things tend to go. repeat this is not concrete news of any actual physical project generating money soon AT ALL
What’s happening? Day traders sending it down? Thought it was heading north???
Why the rise?
Why?